ABSTRACT
Recent progress in fundamental tumor immunology has led to immunotherapy trials in patients with solid tumors and hematological malignancies. In the past, immunotherapy approaches were primarily based on enhancement of tumor immunity with cytokines and adjuvant therapy, without knowledge of relevant tumor antigens. The discovery of tumor antigens c
TABLE OF CONTENTS
part |2 pages
Part 1 Animal models
part |2 pages
Part 2 Human tumor antigens recognized by class I HLA-restricted T cells
part |2 pages
Part 3 Human tumor antigens recognized by class II HLA-restricted T cells
part |2 pages
Part 4 Human tumor antigens recognized by antibodies